Trials / Terminated
TerminatedNCT01315418
Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 239 (actual)
- Sponsor
- Danone Global Research & Innovation Center · Industry
- Sex
- All
- Age
- 18 Years – 29 Years
- Healthy volunteers
- Accepted
Summary
This multicentric, randomized, double-blind and controlled study aims to examine the effect of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel® = tested product) on the incidence of respiratory and gastro-intestinal common infectious diseases (cumulated number of infections during the intervention period: primary criteria), and on the Quality of Life in adults submitted to multi-stressor situation. Volunteers received either 200g/day of tested product (N=121) or control product (N=118) for 7-weeks.
Conditions
- Upper Respiratory Tract Infections
- Rhinopharyngitis
- Sore Throat
- Sinusitis
- Otitis
- Lower Respiratory Tract Infections
- Bronchitis
- Pneumopathy
- Flu
- Flu-like Syndromes
- Gastroenteritis
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®) | |
| OTHER | 2-Non fermented dairy product (control) |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-05-01
- Completion
- 2007-07-01
- First posted
- 2011-03-15
- Last updated
- 2016-11-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01315418. Inclusion in this directory is not an endorsement.